Nano-X Imaging (NNOX) Projected to Post Earnings on Monday

Nano-X Imaging (NASDAQ:NNOX) will likely be posting its Q4 2025 results before the market opens on Monday, March 30th. Analysts expect Nano-X Imaging to post earnings of ($0.15) per share and revenue of $3.9940 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, March 31, 2026 at 12:30 PM ET.

Nano-X Imaging Stock Performance

Shares of NNOX opened at $2.41 on Monday. The firm has a market cap of $157.57 million, a PE ratio of -1.83 and a beta of 1.38. The firm’s 50 day moving average price is $2.64 and its 200 day moving average price is $3.27. Nano-X Imaging has a twelve month low of $2.11 and a twelve month high of $6.22.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Nano-X Imaging in a research note on Monday, December 29th. Cantor Fitzgerald raised shares of Nano-X Imaging to a “strong-buy” rating in a research note on Wednesday, March 4th. Finally, D. Boral Capital reiterated a “buy” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a report on Tuesday, March 3rd. Three investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $7.00.

Hedge Funds Weigh In On Nano-X Imaging

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Aristides Capital LLC bought a new position in shares of Nano-X Imaging in the fourth quarter valued at approximately $30,000. CIBC Bancorp USA Inc. bought a new stake in shares of Nano-X Imaging during the 3rd quarter worth $40,000. BNP Paribas Financial Markets boosted its holdings in shares of Nano-X Imaging by 193.7% during the 2nd quarter. BNP Paribas Financial Markets now owns 11,994 shares of the company’s stock worth $62,000 after buying an additional 7,910 shares during the period. Russell Investments Group Ltd. grew its stake in Nano-X Imaging by 62.1% in the 3rd quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock valued at $51,000 after buying an additional 5,283 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its holdings in Nano-X Imaging by 529.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 13,794 shares of the company’s stock worth $71,000 after acquiring an additional 11,604 shares during the period. Institutional investors and hedge funds own 21.49% of the company’s stock.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.